Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations Nina ShahMatthew SussmanSundar Jagannath Systematic Review 18 February 2021 Pages: 201 - 210
Cannabidiol in the Treatment of Epilepsy Randi von WredeChristoph HelmstaedterRainer Surges Review Article Open access 09 February 2021 Pages: 211 - 220
Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19 Nicolas HoertelMarina Sánchez-RicoAP-HP/Universities/INSERM COVID-19 Research Collaboration and AP-HP COVID CDR Initiative Original Research Article 09 February 2021 Pages: 221 - 233
Correlations Between SGLT-2 Inhibitors and Acute Renal Failure by Signal Detection Using FAERS: Stratified Analysis for Reporting Country and Concomitant Drugs Yukari KatsuharaShunya Ikeda Original Research Article 10 February 2021 Pages: 235 - 243
Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients Elizabeth A. IbiloyeJamie C. BarnerAlyssa M. Peckham Original Research Article 12 February 2021 Pages: 245 - 253
Cost-Effectiveness of Direct Non-Vitamin K Oral Anticoagulants Versus Vitamin K Antagonists for the Management of Patients with Non-Valvular Atrial Fibrillation Based on Available “Real-World” Evidence: The Italian National Health System Perspective Valentina LorenzoniSalvatore PirriGiuseppe Turchetti Original Research Article Open access 15 February 2021 Pages: 255 - 267
Decision Analysis: Omadacycline Relative to Moxifloxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difficile Infection Thomas P. LodiseRohit MistryKenneth LaPensee Original Research Article Open access 19 February 2021 Pages: 269 - 275
Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density Paul D. MillerSteven TroyBruce Mitlak Original Research Article Open access 27 February 2021 Pages: 277 - 285
An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19 Jan HomolakIvan KodvanjVladimir Trkulja Letter to the Editor 19 February 2021 Pages: 287 - 289
Correction to: Ledipasvir–Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection Vasily IsakovNatalia GankinaKonstantin Zhdanov Correction 23 February 2021 Pages: 291 - 291